About InnoSyn
InnoSyn is a Chemicals & Materials company based in Geleen (Netherlands) founded in 2017, and was acquired by Merieux Equity Partners in February 2024. It provides research and development of chemical processes. Its chief executive, as recorded, is Daniel Mink. Its focus areas include Chemicals and Materials Tech, Chemicals Tech, Tech Enabled Services and Project Management.
Company details
InnoSyn was founded in 2017 and is based in Geleen, Netherlands. Operations focus on the chemical and biotechnology sectors, where research and development of processes in biocatalysis, chemocatalysis, and flow chemistry are carried out. Services include the provision of innovative technologies and products such as recombinant pig liver esterases, hydroxy nitrile, and glucose dehydrogenase for industrial applications.
- Headquarters Geleen, Netherlands
- Stage Acquired
- SectorsChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website innosyn.com
- Social LinkedIn Facebook
- Acquired by Merieux Equity Partners (Feb 2024)
- Latest Funding Round$353.65K (USD), Grant
Jan 2024
- InvestorsEuropean Union
& 1 more
- Acquired byMerieux Equity Partners
(Feb 2024)
Funding Insights of InnoSyn
- Total Rounds 1
- Last Round Grant — $353,649
- First Round $353,649
(Jan 2024)
- Investors Count 1
All 1 funding rounds of InnoSyn with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $353,649 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in InnoSyn
InnoSyn has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Merieux Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pivate equity firm that focuses on investing in healthcare and nutrition companies | merieux-partners.com | Lyon, France | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for InnoSyn
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of InnoSyn
14 people are tracked at InnoSyn (6 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Daniel Mink | CEO | Leadership |
Ruben van Summeren | Chief Operations Officer | Leadership |
David Hyett | Chief Financial Officer | Leadership |
Iwona Kaluzna | Commercial Director | Leadership |
Marijn Rijkers | Sr. Program Director | Leadership |
Guy Somers | HR Business Partner | Leadership |
Bart Zijlstra | Mechanical En Process Engineer Bij Innosyn BV | Team |
Bas Ritzen | Scientist | Team |
Marina Ciriani | Flow Chemistry Scientist | Team |
Peter Hermsen | Principal Scientist And Teamleader Organic Chemistry | Team |
Harold Moody | Pilot Plant Manager | Team |
Arne Vancleef | Scientist - Flow Chemistry | Team |
Leonoor Ramakers | Financial Controller | Team |
Martin Schürmann | Principal Scientist | Team |
Complete people profiles for InnoSyn
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of InnoSyn
3 dated milestones of InnoSyn across 7 years, from founding to its latest funding, stage changes and deals.
- Founded InnoSyn is founded.
- Funding First funding round of $354K.
- Exit Acquired by Merieux Equity Partners.
Web traffic of InnoSyn
Websites that share an audience with InnoSyn (innosyn.com).
Websites whose visitors overlap most with InnoSyn. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
flowid.nl | flowid.nl | 100% | #8,981,080 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Innosyn
Complete news archive for InnoSyn
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InnoSyn
InnoSyn was founded in 2017 and raised its 1st funding round 7 years after it was founded.
InnoSyn is headquartered in Geleen, Netherlands. It is registered at Geleen, Limburg, Netherlands.
Daniel Mink is the CEO of InnoSyn, as recorded in our data.
InnoSyn was founded in 2017 and is based in Geleen, Netherlands. Operations focus on the chemical and biotechnology sectors, where research and development of processes in biocatalysis, chemocatalysis, and flow chemistry are carried out. Services include the provision of innovative technologies and products such as recombinant pig liver esterases, hydroxy nitrile, and glucose dehydrogenase for industrial applications.
InnoSyn has 2 investors. Key investors include European Union, and Merieux Equity Partners.
Yes. InnoSyn was acquired by Merieux Equity Partners in February 2024.